Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Hope youll subscribe to this newsletter, and please hit the like button
Verma S, Butler J, Borlaug BA, et al
This article examines the safety profile of taking these medications together, potential interactions, gastrointestinal considerations, and when to seek medical advice
GLP-1 Guide Frequently Asked Questions Semaglutide targets one hormone to help reduce appetite, while Tirzepatide targets two for enhanced fullness and support
Keeping the day and time consistent maintains stable drug levels